Taiwan FDA registration 4a7791e1a15ca6064964a4f24f4f70fd

QuickProfit Yazi Heart 3-in-1 test reagent

TW: 快得利 揣耶濟 心臟三合一檢驗試劑
Taiwan flagTaiwan·Risk Class 2·Quidel Cardiovascular Inc.·Registered Apr 25, 2016 – Apr 25, 2026Expired
Registration details
Analysis ID
4a7791e1a15ca6064964a4f24f4f70fd
Customs Code
DHA05602841001
Company information
Manufacturer Country
United States
Authorized Representative
BIO-CHECK LABORATORIES LTD.
Product details
Intended Use
This reagent was used by immunofluorescence analysis and Alere Triage MeterPro instrument to rapidly quantify the contents of Creatine Kinase MB, Troponin I., and B-type Natriuretic Peptide in whole blood and plasma samples after EDTA anticoagulation.
Product Type (Level 1)
A Clinical chemistry and clinical toxicology
Product Type (Level 2)
A.1660 Quality control materials (analytical and non-analytical); A.1215 Creatine phosphokinase/creatine kinase or isoenzyme testing system; A.1117 B type B natriuretic peptide test system
Import Information
import
Dates and status
Registration Date
Apr 25, 2016
Expiry Date
Apr 25, 2026
About this record

Access comprehensive regulatory information for QuickProfit Yazi Heart 3-in-1 test reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 4a7791e1a15ca6064964a4f24f4f70fd and manufactured by Quidel Cardiovascular Inc.. The authorized representative in Taiwan is BIO-CHECK LABORATORIES LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices